CoinShares Bitcoin ETF
Company Information
Industry
Commodity Contracts Brokers & Dealers
SIC Code
6221
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
DE
Business Address
437 MADISON AVENUE, 28TH FLOOR, NEW YORK, NY, 10022
Mailing Address
437 MADISON AVENUE, 28TH FLOOR, NEW YORK, NY, 10022
Phone
800-617-0004
Fiscal Year End
1231
EIN
000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 10, 2026 | View on SEC |
| 10-Q Quarterly financial report | November 13, 2025 | View on SEC |
| 10-Q Quarterly financial report | August 13, 2025 | View on SEC |
| 8-K Current report of material events | July 25, 2025 | View on SEC |
| 10-Q Quarterly financial report | May 15, 2025 | View on SEC |
Annual Reports
10-K
March 10, 2026
- Provides regulated and accessible exposure to Bitcoin, tracking its performance via the CME CF Bitcoin Reference Rate – New York Variant.
- Successfully completed its first full year of operation in 2025, achieving significant Assets Under Management (AUM) growth and investor adoption.
Related Companies
Companies in the same industry (SIC: 6221)
Osprey Bitcoin Trust
OBTC
Commodity Contracts Brokers & Dealers
GLOBAL MACRO TRUST
Commodity Contracts Brokers & Dealers
GRANT PARK FUTURES FUND LIMITED PARTNERSHIP
Commodity Contracts Brokers & Dealers
NESTOR PARTNERS
Commodity Contracts Brokers & Dealers
Canary Marinade Solana ETF
SOLC
Commodity Contracts Brokers & Dealers
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.